Bronchodilator Hierarchy: SABA vs LABA vs Anticholinergic — Rescue vs Maintenance

Is the patient in acute respiratory distress (wheezing, accessory muscle use, SpO₂ dropping)?

• YES → Administer SABA immediately (albuterol or levalbuterol)

  • Onset: 5–15 minutes — this is the only true rescue bronchodilator
  • Route: nebulizer or MDI with spacer
  • May repeat every 20 min × 3 doses in acute exacerbation
  • Monitor heart rate (tachycardia, tremor = expected side effects)
  • If no improvement after 3 treatments → notify provider for escalation (IV magnesium, epinephrine, intubation readiness)

• NO → The patient is stable. Determine the underlying diagnosis.

COPD maintenance pathway

• First-line: LAMA (long-acting muscarinic antagonist)
  • Tiotropium (Spiriva): once daily
  • Mechanism: blocks acetylcholine → reduces bronchospasm + secretions
  • Teach: rinse mouth after use; report urinary retention, dry mouth, blurred vision
  • Contraindication: allergy to atropine or soy/peanut (some formulations)
• SAMA (short-acting muscarinic antagonist) — ipratropium (Atrovent): QID dosing
  • Same anticholinergic mechanism but short-acting; often paired with albuterol (DuoNeb) in acute COPD exacerbations
• Step up: Add LABA (salmeterol, formoterol) if LAMA alone is insufficient
  • Often combined in one device (e.g., Stiolto, Anoro)
  • LABA monotherapy is acceptable in COPD (no black box for COPD)

Asthma maintenance pathway

• Foundation: Inhaled corticosteroid (ICS) — not a bronchodilator, but required first
  • ICS controls inflammation; without it, bronchodilators alone don't prevent exacerbations
• Step up: Add LABA only in combination with ICS
  • Combination inhalers: fluticasone-salmeterol (Advair), budesonide-formoterol (Symbicort)
  • ⚠ BLACK BOX WARNING: LABA monotherapy in asthma increases risk of asthma-related death
  • LABA must never be prescribed without a concurrent ICS in asthma
  • If the client says they use salmeterol alone for asthma → intervene, notify provider
• LAMA add-on (tiotropium) is now approved as step-up in uncontrolled asthma — but only added to ICS ± LABA, never alone

Universal rule — applies to every patient regardless of diagnosis

• A SABA rescue inhaler must be prescribed alongside any maintenance regimen
• Using the rescue inhaler > 2 days/week (outside of exercise pre-treatment) = poorly controlled disease → reassess maintenance therapy
• SABA overuse (≥ 3 canisters/year) is linked to increased exacerbation and mortality risk

Quick discrimination check before you answer

• Acute distress → SABA (albuterol) — always first, no exceptions
• COPD maintenance → LAMA first, add LABA if needed
• Asthma maintenance → ICS first, add LABA only combined with ICS
• LABA alone in asthma → Wrong answer on the NCLEX, every time